Ajax-Loading

Company Selected - Sinopharm Group Co Ltd - Income Statement















Ajax-Loading
Fiscal Year is From January To December - All Figures are in , Thousands, Except for the Diluted EPS Figure06/30/202503/31/202512/31/202409/30/2024View Chart

Total Revenue

575,824,118584,507,930.00584,507,930590,346,095.00

[-] Cost of Goods Sold (COGS) incl. D&A

532,736,592540,252,540.00540,252,540543,161,803.00

Hid COGS excluding D&A

532,736,592540,252,540.00540,252,540543,161,803.00

Hid Depreciation & Amortization Expense

0.00.00.00.0

Gross Profit

43,087,52644,255,39044,255,39047,184,292

[-] Operating Expenses

27,979,17828,066,98728,066,98728,586,670

Hid Selling General Administrative (SG&A)

24,296,44325,572,183.0025,572,18326,142,577.00

Hid Research & Development

123,355 - - -

Hid Other Operating Expenses

3,559,3802,494,8042,494,8042,444,093

Operating Income

15,108,34816,188,403.0016,188,40318,597,622.00

[-] Net Interest Income

- - - -

Hid Interest Expense

Hid Interest Income

862,9251,003,616.001,003,616983,783.00

Hid Total Other Finance Cost

----

Total Other Income Expense Net

-1,505,852-2,187,504.00-2,187,504-355,027.00

Income Before Tax

13,602,49714,000,899.0014,000,89918,242,595.00

Tax Provision

3,752,6803,577,305.003,577,3054,226,782.00

[-] Net Income Applicable To Common Shares

6,811,4947,049,683.007,049,6838,653,196.00

Hid [-] Net Income

6,803,5227,049,683.007,049,6838,653,196.00

HidHid [-] Net Income Including Non-Controlling Interests

9,849,81710,423,594.0010,423,59414,015,813.00

HidHidHid Net Income From Continuing Ops

- - - -

HidHidHid Discontinued Operations

- - - -

HidHid Minority Interest Expense

3,046,2953,373,911.003,373,9115,362,617.00

Hid Preferred Stock And Other Adjustments

-7,9720.00.00.0

Diluted EPS

2.192.262.262.77

Diluted Average Shares

3,115,058 - 3,113,104 -

EBITDA

20,581,75520,174,941.0020,174,94123,023,483.00

EBIT

17,142,01317,819,063.0017,819,06320,863,154.00